EVP, Chief Compliance Officer of Alexion Pharmaceuticals Inc (30-Year Financial, Insider Trades) Indrani Lall Franchini (insider trades) sold 6,853 shares of ALXN on 06/08/2020 at an average price of $114.69 a share. The total sale was $785,971.
Alexion Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in serving patients with severe and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products. Alexion Pharmaceuticals Inc has a market cap of $25.61 billion; its shares were traded at around $115.99 with a P/E ratio of 10.92 and P/S ratio of 4.90. Alexion Pharmaceuticals Inc had annual average EBITDA growth of 27.30% over the past ten years. GuruFocus rated Alexion Pharmaceuticals Inc the business predictability rank of 3-star. GuruFocus has detected 1 severe warning sign with Alexion Pharmaceuticals Inc. .
Directors and Officers Recent Trades:
- EVP, Chief Compliance Officer Indrani Lall Franchini sold 6,853 shares of ALXN stock on 06/08/2020 at the average price of $114.69. The price of the stock has increased by 1.13% since.
For the complete insider trading history of ALXN, click here
.